Antibiotic-Resistant Infection Treatment
耐药菌感染治疗
- 2-8 weeks depending on infection
- 2-8 weeks post-treatment monitoring
- 91%
China versus the U.S.
- China clinical rate
- $500 – $5,000
- $2,750
- United States
- $10,000 – $50,000
- $30,000
- You save
- ~91%
- $27,250 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Specialized treatment program for multidrug-resistant bacterial infections including MRSA, VRE, and carbapenem-resistant organisms at China's leading infectious disease hospitals. Programs utilize advanced susceptibility testing, combination antimicrobial strategies, and novel therapeutic approaches including phage therapy research. Expert infectious disease consultation ensures optimal treatment outcomes.
Step by step.
Resistance Profiling
Extended antimicrobial susceptibility testing including synergy studies and minimum inhibitory concentration determination
Treatment Strategy Design
Infectious disease specialist consultation to design combination therapy protocol
Targeted Antimicrobial Therapy
IV and/or oral combination antibiotics with close monitoring of drug levels and organ function
Microbiological Cure Confirmation
Repeat cultures and inflammatory markers to confirm infection clearance
- Access to reserve antibiotics at significantly lower cost
- Expert infectious disease specialists with MDR experience
- Advanced microbiological laboratory capabilities
- Emerging therapies including phage therapy protocols
- Toxicity from high-dose antibiotic combinations
- Treatment failure requiring alternative strategies
- Clostridium difficile infection from broad-spectrum agents
- Prolonged hospitalization for severe cases
Ask the AI for hospitals that handle antibiotic-resistant infection treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.